Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Xos (XOS) Q2 2025 Earnings Call Transcript
Xos (XOS) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Aug. 13, 2025 at 4:30 p.m. ET

Chief Executive Officer — Dakota Semler

Continue reading

Source Fool.com

CMCT Leasing Surges as NOI Drops in Q2
CMCT Leasing Surges as NOI Drops in Q2

Creative Media & Community Trust (NASDAQ:CMCT) reported fiscal Q2 2025 results on Aug. 12, 2025, highlighting a core funds from operations (FFO) loss of $7.2 million and a year-over-year increase of

Longeveron Posts 32% Revenue Drop in Q2Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Longeveron Posts 32% Revenue Drop in Q2

Longeveron (NASDAQ:LGVN), a clinical-stage biotechnology firm focused on stem cell therapies for rare and aging-related diseases, released its second quarter earnings on August 13, 2025.

The most

Tenon Medical Revenue Falls 37 PercentPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Tenon Medical Revenue Falls 37 Percent

Tenon Medical(NASDAQ:TNON) reported results for the fiscal second quarter ended June 30, 2025, on August 6, 2025, emphasizing the completed CyVantage acquisition, a 29% year-over-year drop in

Tenon Medical (TNON) Q2 2025 Earnings TranscriptPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Tenon Medical (TNON) Q2 2025 Earnings Transcript

Image source: The Motley Fool.

Aug. 13, 2025, at 4:30 p.m. ET

Chief Executive Officer — Steven Foster

Continue reading

Source Fool.com

IceCure Medical Advances FDA ReviewPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
IceCure Medical Advances FDA Review

IceCure Medical(NASDAQ:ICCM) reported second-quarter 2025 results on Aug. 13, 2025, with revenue declining year-over-year to $1.25 million from $1.75 million for the six months ended June 30, 2025

Barfresh Q2 Revenue Up 11 PercentPhoto, wide shot, wide-angle lens,  Brewery, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.theapi.app/temp/0cebecb6-c4f6-4c6e-b73e-f375daba8100.png
Barfresh Q2 Revenue Up 11 Percent

Barfresh Food Group (NASDAQ:BRFH) reported second quarter 2025 results on August 13, 2025, highlighting 11% year-over-year revenue growth to $1.6 million (GAAP) in Q2 FY2025 and milestone

Barfresh (BRFH) Q2 2025 Earnings Call Transcript
Barfresh (BRFH) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Wednesday, August 13, 2025 at 4:30 p.m. ET

Chief Executive Officer — Riccardo Delle Coste

Continue reading

Source Fool.com

Forian Revenue Jumps 56 Percent in Q2Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Forian Revenue Jumps 56 Percent in Q2

Forian (NASDAQ:FORA), a healthcare and life sciences data analytics provider, reported better-than-expected Q2 2025 results (GAAP), released on August 13, 2025. The company posted GAAP revenue of

Aardvark Therapeutics Reports Q2 Loss
Aardvark Therapeutics Reports Q2 Loss

Aardvark Therapeutics (NASDAQ:AARD), a clinical-stage biopharmaceutical company developing new treatments for rare and metabolic diseases, reported its financial results on August 13, 2025. The most

Red Robin Swings to Profit in Fiscal Q2
Red Robin Swings to Profit in Fiscal Q2

Red Robin Gourmet Burgers (NASDAQ:RRGB), a family-friendly, casual-dining chain known for gourmet burgers and bottomless sides, released its fiscal second quarter 2025 results on August 13, 2025

Jade Biosciences Posts Wider Loss in Q2
Jade Biosciences Posts Wider Loss in Q2

Jade Biosciences (NASDAQ:JBIO), a biotechnology company focused on autoimmune disease therapies, published its results on August 13, 2025. The standout message: the company reported a GAAP net loss

Expion360 (XPON) Q2 2025 Earnings Call Transcript
Expion360 (XPON) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Wednesday, August 13, 2025 at 4:30 p.m. ET

Chief Executive Officer and Interim Chief Financial Officer — Brian Schaffner

Continue reading

Source Fool.com

Forian Q2 Revenue Jumps 56 Percent
Forian Q2 Revenue Jumps 56 Percent

Forian (NASDAQ:FORA) reported second-quarter 2025 results on August 13, 2025, delivering GAAP revenue of $7.5 million, representing 56% year-over-year growth and net income (GAAP) of $224,000

Coherent Posts 16% Revenue Gain in Q4Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Coherent Posts 16% Revenue Gain in Q4

Coherent (NYSE:COHR), a technology leader in photonic and engineered material solutions, reported earnings for Q4 FY2025 on August 13, 2025. The company posted GAAP revenue of $1.53 billion for Q4

Noodles and Co Posts Wider Loss in Q2Photo, wide shot, wide-angle lens,  Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/bda07ced-e79e-4489-b731-ada601660c8e.png
Noodles and Co Posts Wider Loss in Q2

Noodles & Co (NASDAQ:NDLS), a fast-casual dining chain specializing in globally inspired noodle dishes, reported earnings for Q2 2025 on August 13, 2025. It missed analyst estimates for both GAAP

Surf Air Mobility Revenue Tops Forecast
Surf Air Mobility Revenue Tops Forecast

Surf Air Mobility(NYSE:SRFM) reported fiscal second quarter 2025 results on August 12, 2025 (period ended June 30, 2025), with revenue reaching $27.4 million, exceeding guidance, and adjusted EBITDA

Why the Cryptocurrency OKB Was Up More Than 192% Today
Why the Cryptocurrency OKB Was Up More Than 192% Today

The crypto token OKB (CRYPTO: OKB) is exploding today, up 121.8% in the last 24 hours as of 3:45 p.m. ET, having gained as much as 192.3% earlier in that period. The jump comes as the S&P 500 and

Cisco Posts 8 Percent Gain in Fiscal Q4Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.theapi.app/temp/bee95973-d201-429b-849e-52867059bd1a.png
Cisco Posts 8 Percent Gain in Fiscal Q4

Cisco (NASDAQ:CSCO), a global leader in networking hardware and software, reported its earnings for the fiscal fourth quarter ended July 26, 2025, on August 13, 2025. The company posted revenue of

Why Interactive Brokers Stock Slumped by 6% Today
Why Interactive Brokers Stock Slumped by 6% Today

Investors didn't want to interact much with Interactive Brokers (NASDAQ: IBKR) on Wednesday. They were reacting to an announcement by the global securities brokerage that it wouldn't be drawing a

Ampco-Pittsburgh Reports Record ProfitPhoto, wide shot, wide-angle lens,  Clothing manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/7d69264d-49b2-466c-9987-b2706836d522.png
Ampco-Pittsburgh Reports Record Profit

Ampco-Pittsburgh(NYSE:AP) reported second-quarter 2025 results on Aug. 12, posting a net loss of $7.3 million (GAAP) due to a $6.8 million United Kingdom plant exit charge. Management announced

LiqTech International Lifts 2025 Outlook
LiqTech International Lifts 2025 Outlook

LiqTech International (NASDAQ:LIQT) reported second-quarter 2025 results on Aug. 13, 2025, delivering almost $5 million in revenue. Revenue was up quarter over quarter, and management set a

Vaxart Revenue Jumps 520% in Fiscal Q2Photo, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
Vaxart Revenue Jumps 520% in Fiscal Q2

Vaxart (OTC:VXRT), a biotechnology company focused on developing oral tablet vaccines for infectious diseases, reported its second quarter results on August 13, 2025. The standout headline was a

Vinci Partners AUM Hits $56 BillionPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Vinci Partners AUM Hits $56 Billion

Vinci Partners Investments (NASDAQ:VINP) reported second quarter 2025 results on Aug. 12, 2025, with 65.2 million Brazilian reals (BRL) in fee-related earnings (non-GAAP), BRL75.8 million in

Allogene Narrows Loss in Fiscal Q2Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Allogene Narrows Loss in Fiscal Q2

Allogene Therapeutics (NASDAQ:ALLO), a biotechnology company developing off-the-shelf cell therapies for cancer and autoimmune diseases, reported its second quarter 2025 results on August 13, 2025